Journal
BRAIN RESEARCH
Volume 1362, Issue -, Pages 13-22Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.brainres.2010.09.073
Keywords
Biomarker; Neurogranin; Synaptic degeneration; Mild Cognitive impairment; Alzheimer's disease
Categories
Funding
- Aina Wallstroms och Mary-Ann Sjobloms stiftelse
- Demensfonden
- Martha och Gustaf Agrens stiftelse
- Stiftelsen Gamla tjanarinnor
- Stiftelsen Lars Hiertas Minne
- Stohnes stiftelse
- Wilhelm och Martina Lundgrens vetenskapsfond
Ask authors/readers for more resources
Synaptic pathology occurs early in Alzheimer's disease (AD) development, and cerebrospinal fluid biomarkers for synaptic damage may be altered early in the disease process. In the present study we examined cerebrospinal fluid levels of the postsynaptic protein neurogranin in patients with mild cognitive impairment (MCI) or AD and controls. The low neurogranin level in cerebrospinal fluid required enrichment by immunoprecipitation prior to mass spectrometric identification and semi-quantitative immunoblot analysis. Relative quantification revealed a significant increase of neurogranin in the AD group compared with controls, while the MCI group was not statistically different from either controls or the AD group. The concentrations of the AD biomarkers T-tau, P-tau(181) and A beta(42) were significantly changed in the control and MCI groups compared with the AD group, but no significant differences were found between the MCI group and controls for the three biomarkers. Nevertheless, a trend towards increasing levels of neurogranin, T-tau and P-tau(181) was found in cerebrospinal fluid from MCI patients compared with controls. The elevated neurogranin levels in the MCI and AD groups might reflect synaptic degeneration. These results together suggest that cerebrospinal fluid neurogranin might be valuable together with the established AD biomarkers in the early diagnosis of AD and warrants further studies to determine the diagnostic value of neuroganin. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available